Graphene Oxide⁻Platinum Nanoparticle Nanocomposites: A Suitable Biocompatible Therapeutic Agent for Prostate Cancer.

Polymers (Basel) · 2019 · PMC6523086 · PMID 31018506

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

As shown in Figure 10 B, compared with that in the control, treatment of LNCaP cells with GO, PtNPs, and GO-PtNPs resulted in a decreased level of ATP, but these decreases were highly significant in the latter treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.